Eurofins Scientifi (NASDAQ:ERFSF) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a note issued to investors on Thursday. The firm currently has a $717.00 price objective on the stock. Zacks Investment Research‘s target price indicates a potential upside of 14.10% from the stock’s current price.

According to Zacks, “Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. “

TRADEMARK VIOLATION WARNING: “Zacks Investment Research Upgrades Eurofins Scientifi (ERFSF) to “Strong-Buy”” was published by American Banking News and is owned by of American Banking News. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/11/02/zacks-investment-research-upgrades-eurofins-scientifi-erfsf-to-strong-buy.html.

Get a free copy of the Zacks research report on Eurofins Scientifi (ERFSF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Eurofins Scientifi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scientifi and related companies with MarketBeat.com's FREE daily email newsletter.